Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients

BACKGROUND: The ZHX family has recently been in the spotlight as an integrator and an indispensable node in carcinogenesis, whose expression is frequently dysregulated in multiple cancers. The current study provides a novel investigation of the expression profiles of ZHX factors in breast cancer. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Yanjie, Ma, Yuhong, Wang, Qiang, Ye, Zhengcai, Deng, Yanhong, Bai, Feihu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368119/
https://www.ncbi.nlm.nih.gov/pubmed/30787639
http://dx.doi.org/10.2147/CMAR.S184340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368119/
https://www.ncbi.nlm.nih.gov/pubmed/30787639
http://dx.doi.org/10.2147/CMAR.S184340

Ejemplares similares